Results 131 to 140 of about 63,993 (197)

Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment. [PDF]

Brain Sci
Chiappini S, Corkery JM, Guirguis A, Mosca A, Murray M, Arillotta D, Dattoli L, Martinotti G, Bonaccorso S, Schifano F, Schifano N.   +10 more
europepmc   +1 more source

Metoclopramide and Risk of Pheochromocytoma Crisis: A Causality Assessment Using Literature and VigiBase Data. [PDF]

Drug Healthc Patient Saf
Bahta M, Dawit A, Okubazghi M, Russom M.
europepmc   +1 more source

Reply : Primary suspect drugs of cataracts in pediatric patients: FDA adverse events reporting database analysis. [PDF]

J Cataract Refract Surg
Khan SM, Abboud I, Elhusseiny AM, Elhusseiny AM.   +3 more
europepmc   +1 more source

Incorporating patient-reported outcome measures into routine paediatric pharmacovigilance: opportunities for safety monitoring with practical use scenarios from paediatric oncology. [PDF]

Front Pharmacol
Teodoro P, Fernandes RM, Ribeiro I, Ferreira-da-Silva R.   +3 more
europepmc   +1 more source

Trends in adverse drug reaction reporting by dentists: a 15-year analysis of German pharmacovigilance data. [PDF]

Clin Oral Investig
Halling F, Lutz R, Meisgeier A.
europepmc   +1 more source

Secondary data analysis of Adverse Drug Reactions reported by healthcare professionals and patients: interventions to manage ADRs of ACE inhibitors and ARBs. [PDF]

Eur J Clin Pharmacol
Spronk SH, Nielen JTH, Heier L, Jessurun N, Kant A, Karapinar-Çarkit F.   +5 more
europepmc   +1 more source

Signals of Toxicity Associated With Gene Therapy: The Case of Etranacogene Dezaparvovec in the Treatment of Hemophilia B. [PDF]

J Pharm Technol
Castellana E, Chiappetta MR.
europepmc   +1 more source

The Role of Electronic Medical Record Systems and Pharmacovigilance Databases in the Surveillance of Antimicrobial Use and Resistance in Low- and Middle-Income Countries: Protocol for a Multistudy Project. [PDF]

JMIR Res Protoc
Saleh H, Stålsby Lundborg C, Sharma M.
europepmc   +1 more source

Bridging the Gap: Promoting Adverse Drug Reaction Reporting through Innovative Strategies in Zero-reporting Zones at Karaikal - An Educational Intervention Study at Adverse Drug Reaction Monitoring Center. [PDF]

J Res Pharm Pract
Palanisamy PR, Kiruthika S, Ravichandran D.   +2 more
europepmc   +1 more source

NAPaR : European non-interventional post-authorisation safety study of pattern of use and safety of Nordic aprotinin [PDF]

, 2019
De Hert, Stefan, Ouattara, A., Royston, D., Van Der Linden, J., Zacharowski, K.   +4 more
core